2024 Q2 Form 10-Q Financial Statement

#000121465924008656 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $37.00K $36.00K $45.00K
YoY Change 5.71% -20.0% 0.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $78.00K $78.00K $68.00K
YoY Change -3.7% 14.71% -15.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.000K $3.000K $3.000K
YoY Change 33.33% 0.0% 0.0%
% of Gross Profit
Operating Expenses $90.00K $91.00K $80.00K
YoY Change -5.26% 13.75% -13.04%
Operating Profit -$53.00K -$55.00K -$35.00K
YoY Change -11.67% 57.14% -25.53%
Interest Expense $56.00K $57.00K $52.00K
YoY Change 3.7% 9.62%
% of Operating Profit
Other Income/Expense, Net $56.00K $57.00K $52.00K
YoY Change 3.7% 9.62%
Pretax Income $3.000K $2.000K $17.00K
YoY Change -150.0% -88.24% 240.0%
Income Tax
% Of Pretax Income
Net Earnings $3.000K $2.000K $17.00K
YoY Change -150.0% -88.24% 240.0%
Net Earnings / Revenue 8.11% 5.56% 37.78%
Basic Earnings Per Share $0.01 $0.01 $0.01
Diluted Earnings Per Share $0.01 $0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 5.132M shares 5.132M shares 5.132M shares
Diluted Shares Outstanding 5.132K shares 5.132K shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $416.0K $395.0K $437.0K
YoY Change -3.7% -9.61% 72.05%
Cash & Equivalents $416.0K $395.0K $437.0K
Short-Term Investments
Other Short-Term Assets $40.00K $61.00K $62.00K
YoY Change -11.11% -1.61% 63.16%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $456.0K $456.0K $4.041M
YoY Change -88.65% -88.72% 4.8%
LONG-TERM ASSETS
Property, Plant & Equipment $622.0K $626.0K $628.0K
YoY Change -0.48% -0.32% -1.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $4.164M $4.168M $628.0K
YoY Change 566.24% 563.69% -1.88%
TOTAL ASSETS
Total Short-Term Assets $456.0K $456.0K $4.041M
Total Long-Term Assets $4.164M $4.168M $628.0K
Total Assets $4.620M $4.624M $4.669M
YoY Change -0.52% -0.96% 3.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.00K $25.00K $55.00K
YoY Change 5.0% -54.55% -16.67%
Accrued Expenses $39.00K $42.00K $21.00K
YoY Change 5.41% 100.0% -4.55%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $60.00K $67.00K $76.00K
YoY Change 5.26% -11.84% -20.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $60.00K $67.00K $76.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $60.00K $67.00K $76.00K
YoY Change 5.26% -11.84% -20.83%
SHAREHOLDERS EQUITY
Retained Earnings -$59.07M -$59.07M -$59.04M
YoY Change 0.05% 0.06%
Common Stock $51.00K $51.00K $51.00K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.560M $4.557M $4.593M
YoY Change
Total Liabilities & Shareholders Equity $4.620M $4.624M $4.669M
YoY Change -0.52% -0.96% 3.85%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $3.000K $2.000K $17.00K
YoY Change -150.0% -88.24% 240.0%
Depreciation, Depletion And Amortization $4.000K $3.000K $3.000K
YoY Change 33.33% 0.0% 0.0%
Cash From Operating Activities $21.00K -$52.00K $1.000K
YoY Change -520.0% -5300.0% -50.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 21.00K -$52.00K $1.000K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash 21.00K -$52.00K $1.000K
YoY Change -520.0% -5300.0%
FREE CASH FLOW
Cash From Operating Activities $21.00K -$52.00K $1.000K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
000-08187
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1603 LBJ Freeway
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
CY2024Q1 dei City Area Code
CityAreaCode
(972)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
407-8400
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
CY2024Q1 dei Trading Symbol
TradingSymbol
GBR
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5131934 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
395000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
447000 usd
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
61000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
12000 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
456000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
459000 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
626000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
629000 usd
CY2024Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
3542000 usd
CY2023Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
3542000 usd
CY2024Q1 us-gaap Assets
Assets
4624000 usd
CY2023Q4 us-gaap Assets
Assets
4630000 usd
CY2024Q1 GBR Due To Related Parties
DueToRelatedParties
8000 usd
CY2023Q4 GBR Due To Related Parties
DueToRelatedParties
8000 usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
25000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36000 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39000 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
67000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
75000 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1 shares
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5131934 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5131934 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5131934 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5131934 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
51000 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63579000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63579000 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59074000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59076000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4557000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4555000 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4624000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4630000 usd
CY2024Q1 us-gaap Revenues
Revenues
36000 usd
CY2023Q1 us-gaap Revenues
Revenues
45000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
13000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
12000 usd
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
78000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
68000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
91000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
80000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-55000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-35000 usd
CY2024Q1 GBR Interest Income From Relatedparty
InterestIncomeFromRelatedparty
57000 usd
CY2023Q1 GBR Interest Income From Relatedparty
InterestIncomeFromRelatedparty
52000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
57000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
52000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
17000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5132 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5132 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5132 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5132 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4555000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4557000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4576000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
17000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4593000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
17000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
49000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
32000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-8000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
13000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-52000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-52000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
447000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
436000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
395000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
437000 usd
CY2024Q1 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80D_eus-gaap--NatureOfOperations_zh4R1bSO3KD" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>NOTE B: <span id="xdx_82E_zOLGShZIrbk8">NATURE OF OPERATIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company owns approximately 190 acres of land located in Parkersburg, West Virginia. Located on the land are four structures totaling approximately 53,000 square feet. Of this total area the main industrial/office building contains approximately 24,800 square feet of which approximately 16,000 square feet is leased at a rate of $<span id="xdx_90A_ecustom--LeaseRevenueperAnnum_c20240101__20240331" title="Lease revenue per annum">101,000 per annum</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In August 2020, the Company sold its oil and gas operations to a third party. On January 1, 2022, the Company entered into a Consulting Management Agreement with respect to such oil and gas operations whereby the Company would provide management, supervisory and administrative services for a fee of 10% of the gross revenue of such oil and gas operations. The agreement is effective January 1, 2022 and may be terminated by either party upon sixty days’ notice.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">  </p>
CY2024Q1 GBR Lease Revenueper Annum
LeaseRevenueperAnnum
101,000 per annum
CY2024Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000000 usd

Files In Submission

Name View Source Status
0001214659-24-008656-index-headers.html Edgar Link pending
0001214659-24-008656-index.html Edgar Link pending
0001214659-24-008656.txt Edgar Link pending
0001214659-24-008656-xbrl.zip Edgar Link pending
d5724310q.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gbr-20240331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d5724310q_htm.xml Edgar Link completed
gbr-20240331_def.xml Edgar Link unprocessable
gbr-20240331_cal.xml Edgar Link unprocessable
gbr-20240331_pre.xml Edgar Link unprocessable
gbr-20240331_lab.xml Edgar Link unprocessable